Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Psyence Australia Pty Ltd
Daiichi Sankyo
Mayo Clinic
Fudan University
Seagen Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
Exelixis
Convalife (Shanghai) Co., Ltd.
Brown University
Memorial Sloan Kettering Cancer Center
Astellas Pharma Inc
National Cancer Institute (NCI)